Patent details

EP1307197 Title: COMPOSITIONS FOR THE TREATMENT OF CANCER COMPRISING A TOPOISOMERASE INHIBITOR AND THALIDOMIDE

Basic Information

Publication number:
EP1307197
PCT Application Number:
PCT/US/2001/015327
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019353739
PCT Publication Number:
WO/2001/087307
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMPOSITIONS FOR THE TREATMENT OF CANCER COMPRISING A TOPOISOMERASE INHIBITOR AND THALIDOMIDE
French Title of Invention:
COMPOSITIONS POUR LE TRAITEMENT DU CANCER CONTENANT UN INHIBITEUR DE TOPOISOMERASE ET THALIDOMIDE
German Title of Invention:
PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON KREBS WELCHE THALIDOMID UND TOPOISOMERASE INHIBITOREN ENTHALTEN
SPC Number:

Dates

Filing date:
10/05/2001
Grant date:
05/04/2006
EP Publication Date:
05/04/2006
PCT Publication Date:
22/11/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/05/2003
EP B1 Publication Date:
05/04/2006
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/05/2015
Expiration date:
10/05/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/01/2007
 
 

Name:
CELGENE CORPORATION
Address:
MORRIS AVENUE 86, 07901, SUMMIT, NEW JERSEY, United States (US)

History of Owners

From:
18/05/2006
To:
11/01/2007

Name:
CELGENE CORPORATION
Address:
86 Morris Avenue, Summit, New Jersey 07901, United States (US)

Agent

Name:
DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
From:
05/05/2006
Address:
PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
ZELDIS Jerome, B.
Address:
United States (US)

2

Name:
ZEITLIN Andrew
Address:
United States (US)

3

Name:
BARER Sol
Address:
United States (US)

Priority

Priority Number:
204143 P
Priority Date:
15/05/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/47;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages